Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Oxfordshire based Founder operating in the Health Diagnostics space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Mayank Banerjee
Co-Founder and CEO of Even
Mayank Banerjee joined Even Healthcare as Co-Founder in 2020.
Follow Mayank Banerjee:
About Even: Even is a health-tech company and healthcare provider that partners directly with the top hospitals in the country.
Connor Campbell
Founder and CEO of Osler Diagnostics
Follow Connor Campbell:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Paulo R. Bueno
Co-Founder of Osler Diagnostics
Paulo R. Bueno is the coordinator of the Nanobionics research group (www.nanobionics.pro.br) at São Paulo State University, UNESP. He published over 180 papers related to fundaments and applications of electric and electrochemistry time-dependent (including gravimetric and optical impedance) spectroscopic methods (h index 42, > 6500 citations with an average citation of higher than 25 per article, Google Scholar). His main scientific interest is focused on the fundaments and technological applications associated with electron charge transfer, transport and storage occurring at molecular and nanoscale structures. Under his guidance Nanobionics group develops synthetic structures and surfaces that mimic molecular and biological structures aiming applications in highly-relevant diagnostic devices. The Nanobionics group developed a totally new label-free diagnostic assay based on an electroanalytical spectroscopic methodology supported on the use of the electrochemistry capacitance, i.e. a capacitance proportional to the electrochemical density of states that intrinsically exists in mesoscopic structures comprised of redox-active molecules when attached over an electrode. These impedance-derived assays are able to detect target protein at femtomolar levels allowing the early detection of clinically relevant targets that are better than those currently commercial. They are potentially cheap and can be multiplexed. Other relevant aspects of his groups’ activities are the synthesis of self-assembled redox-tagged peptides and its applications in redox capacitive biosensors. The advantages of constructing a peptide-based receptive surface containing electrochemical tags are that peptides can be easily manipulated and optimized for applications containing complex biological environments. This tailoring ability avoids fouling and concomitantly can substitute antibodies by peptide or DNA aptamers as receptors with equivalent or superior affinity as well as specificity. Since 2008 Professor Bueno is engaged with tech transfer initiatives involving public-private start-up tech transfer projects with Scientific and Technological Parks in Sao Paulo. Because of such initiatives, Professor Bueno was invited to a plenary conference in the USA – Washington in 2009 by the US National Council of Entrepreneurial Tech Transfer in which Brazilian Tech Transfer context was introduced and discussed with the US and European Tech Transfer related agents and agencies. He is also engaged with UNESP internationalization program. Finally, he acted as academic and researcher visitor several times in European universities such as Universities of Valence and Jaume I (Spain), University of Paris (France) and University of Oxford. His collaborative work has been the subject of two significant awards from The Royal Society in the UK (a Brian Mercer Award in 2013 and a Newton Fellowship in 2015). His is currently administrating a Fellowship of Royal Society (Research Fellows Director, https://royalsociety.org/people/paulo-roberto-bueno-12682/). He is Fellows of Royal Society of Chemistry (FRSC) in the UK and member of American Chemical Society (ACS) in the USA. Also, he is a member of The Electrochemical Society (ECS) and International Society of Electrochemistry (ISE). Professor Bueno is the co-founder of Osler Diagnostics (http://oslerdiagnostics.com/), a start-up company from the University of Oxford.
Follow Paulo R. Bueno:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Andrew Barker
Co-Founder & Director of Intelligent Ultrasound
Andrew Barker is the Chairman at Oxford Brain Diagnostics .
Follow Andrew Barker:
About Anchard Associates, Brainomix, Intelligent Ultrasound, Oxford Brain Diagnostics: Intelligent Ultrasound develops software that improves the quality, reliability, and diagnostic power of medical ultrasound.
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Patrick Albers
Co-Founder and Head of Technology of BioMe Oxford
Follow Patrick Albers:
About BioMe Oxford, Wellcome Trust Sanger Institute: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Lukas Lange
CEO and Co-Founder of Probably Genetic
Follow Lukas Lange:
About Probably Genetic: Probably Genetic helps rare genetic disease patients.
Charalambos Antoniades
Founder and Chief Scientific Officer of Caristo Diagnostics
Follow Charalambos Antoniades:
About Caristo Diagnostics: Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques
Jonathan Allis
Co-Founder & CEO of Blue Earth Diagnostics
Jonathan Allis is the founding CEO of Blue Earth Diagnostics. Prior to this role, Jonathan was the General Manager for PET at GE Healthcare Life Sciences, and had global responsibility for GE Healthcare’s PET agent and PET synthesis platforms business. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc., Siemens Medical Solutions and Oxford Magnet Technology, in the UK, USA and Germany. Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in biochemistry from the University of Oxford.
Follow Jonathan Allis:
About Blue Earth Diagnostics: BlueEarth Diagnostics mission is to transform the clinical management of recurrent prostate cancer
